Weekly Versus Bolus Cisplatin Concurrent With Definitive Radiation Therapy for Squamous Carcinoma of the Head and Neck: A Systematic Review and Network Meta-Analysis-Reference-Cited by-同舟云学术

Weekly Versus Bolus Cisplatin Concurrent With Definitive Radiation Therapy for Squamous Carcinoma of the Head and Neck: A Systematic Review and Network Meta-Analysis

Published:2024-06 Issue: Volume: Page:
ISSN:1879-8500
Container-title:Practical Radiation Oncology
language:en
Short-container-title:Practical Radiation Oncology

Author:

Ward Matthew C.^ORCID,Prabhu Roshan S.,Atlas Jennifer L.,Carrizosa Daniel R.,Milas Zvonimir L.,Brickman Daniel S.,Frenkel Catherine H.,Hong Steven S.,Moeller Benjamin J.

Publisher

Elsevier BV

Reference31 articles.

1. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer;Adelstein;J Clin Oncol,2003

2. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients;Pignon;Radiother Oncol,2009

3. Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity;Nguyen-Tan;J Clin Oncol,2014

4. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival;Bonner;Lancet Oncol,2010

5. Concurrent cetuximab-based bioradiotherapy versus cisplatin-based chemoradiotherapy in the definitive management of favourable biology human papillomavirus-associated oropharyngeal squamous cell carcinoma: systematic review and meta-analysis;Swain;Clin Oncol,2022